Alyeska Investment Group L.P. Takes Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Alyeska Investment Group L.P. acquired a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 800,000 shares of the construction company's stock, valued at approximately $9,504,000. Alyeska Investment Group L.P. owned 0.98% of Aspen Aerogels as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ASPN. Sanders Morris Harris LLC lifted its position in shares of Aspen Aerogels by 337.5% during the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company's stock worth $436,000 after purchasing an additional 27,000 shares in the last quarter. Vanguard Group Inc. boosted its position in Aspen Aerogels by 5.5% in the 4th quarter. Vanguard Group Inc. now owns 4,360,246 shares of the construction company's stock valued at $51,800,000 after buying an additional 226,251 shares during the period. Barclays PLC grew its stake in shares of Aspen Aerogels by 16.8% in the fourth quarter. Barclays PLC now owns 107,764 shares of the construction company's stock worth $1,280,000 after acquiring an additional 15,462 shares in the last quarter. Swiss National Bank increased its position in shares of Aspen Aerogels by 1.9% during the fourth quarter. Swiss National Bank now owns 128,800 shares of the construction company's stock worth $1,530,000 after acquiring an additional 2,400 shares during the period. Finally, MetLife Investment Management LLC increased its position in shares of Aspen Aerogels by 6.3% during the fourth quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company's stock worth $425,000 after acquiring an additional 2,118 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Stock Performance

NYSE ASPN traded up $0.64 during trading hours on Friday, hitting $4.95. The company had a trading volume of 3,835,747 shares, compared to its average volume of 1,930,003. The business has a 50 day moving average of $6.12 and a 200-day moving average of $10.70. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $33.15. The company has a market cap of $406.42 million, a PE ratio of 30.94 and a beta of 2.72.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. The business had revenue of $78.72 million for the quarter, compared to analyst estimates of $82.75 million. During the same period last year, the firm posted ($0.02) earnings per share. The company's revenue for the quarter was down 16.7% compared to the same quarter last year. As a group, equities research analysts expect that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Canaccord Genuity Group lowered their target price on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research note on Friday, February 14th. Barclays cut their target price on shares of Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 19th. Roth Mkm reduced their target price on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a report on Friday, February 14th. TD Cowen upgraded shares of Aspen Aerogels to a "strong-buy" rating in a report on Tuesday, March 11th. Finally, Craig Hallum reduced their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of "Moderate Buy" and a consensus target price of $19.11.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.